Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to WinZacks Investment Research • 10/01/26
Who Are You Calling Passive? Many Index ETFs Dynamically Rebalanced in SeptemberETF Trends • 09/28/26
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 CoverageZacks Investment Research • 07/01/26
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to GainZacks Investment Research • 05/19/26
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookZacks Investment Research • 02/04/26
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFsBenzinga • 09/18/25